EP2937083

Formulations, salts and polymorphs of transnorsertraline and uses thereof

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    3.12.2010
  • EP published:
    27.3.2019
  • EP application number:
    15150813.2
  • Max expiry date:
    2.12.2030
  • Title:
    Formulations, salts and polymorphs of transnorsertraline and uses thereof

Timeline

Today
3.12.2010EP application
27.3.2019EP Publication

Owner

  • Name:
    Sunovion Pharmaceuticals Inc.
  • Address:
    84 Waterford Drive, 01752, Marlborough, MA, US

Inventor

  • Name:
    Laughlin, Sharon M.
  • Address:
    Marlborough, MA, US
  • Name:
    Sizensky, Michael J.
  • Address:
    Marlborough, MA, US
  • Name:
    Singh, Surendra P.
  • Address:
    Marlborough, MA, US
  • Name:
    Wilkinson, Scott H.
  • Address:
    Marlborough, MA, US
  • Name:
    Huang, Cai Gu
  • Address:
    Marlborough, MA, US
  • Name:
    Bonasia, Philip James
  • Address:
    Marlborough, MA, US
  • Name:
    D'Souza, Susan S.
  • Address:
    Marlborough, MA, US

Priority

  • Number:
    266864 P
  • Date:
    4.12.2009
  • Country:
    US

Classification

  • Categories:
    A61K 31/135, A61K 31/70, A61P 25/00, A61K 9/20

Upload documents